[Abstract] #88 Initial safety and efficacy study demonstrates promise for the use of β2-adrenergic agonists and α-adrenergic antagonists as joint sparing treatments

Dianne Lorton, Cheri L. Lubahn, Jill A. Schaller, Jeffery L. Carter, Carlo Woods, Denise L. Bellinger

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBrain Behavior and Immunity
Volume19
DOIs
StatePublished - Jul 1 2005

Disciplines

  • Biology
  • Endocrinology, Diabetes, and Metabolism
  • Internal Medicine
  • Endocrinology

Cite this